Market Closed -
Japan Exchange
01:59:24 2024-04-30 am EDT
|
5-day change
|
1st Jan Change
|
570
JPY
|
-2.40%
|
|
-5.63%
|
-7.77%
|
Fiscal Period: October |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,237
|
7,624
|
9,432
|
11,967
|
10,127
|
8,952
|
Enterprise Value (EV)
1 |
27,175
|
30,251
|
30,569
|
32,097
|
30,760
|
24,680
|
P/E ratio
|
24.9
x
|
25.2
x
|
13.3
x
|
12.8
x
|
16.1
x
|
1,491
x
|
Yield
|
2.8%
|
1.92%
|
1.66%
|
1.69%
|
2.26%
|
2.56%
|
Capitalization / Revenue
|
0.19
x
|
0.25
x
|
0.28
x
|
0.33
x
|
0.26
x
|
0.22
x
|
EV / Revenue
|
0.97
x
|
0.98
x
|
0.9
x
|
0.88
x
|
0.8
x
|
0.6
x
|
EV / EBITDA
|
16.1
x
|
12.5
x
|
11.1
x
|
11
x
|
11.9
x
|
20.6
x
|
EV / FCF
|
69.6
x
|
22.9
x
|
16.5
x
|
47.1
x
|
-93.6
x
|
-48.4
x
|
FCF Yield
|
1.44%
|
4.36%
|
6.06%
|
2.12%
|
-1.07%
|
-2.07%
|
Price to Book
|
1.46
x
|
1.74
x
|
1.85
x
|
1.77
x
|
1.57
x
|
1.63
x
|
Nbr of stocks (in thousands)
|
13,545
|
13,695
|
13,455
|
13,461
|
13,467
|
13,482
|
Reference price
2 |
386.7
|
556.7
|
701.0
|
889.0
|
752.0
|
664.0
|
Announcement Date
|
1/30/19
|
1/30/20
|
1/29/21
|
1/28/22
|
1/27/23
|
1/30/24
|
Fiscal Period: October |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
28,120
|
30,964
|
33,984
|
36,361
|
38,398
|
41,098
|
EBITDA
1 |
1,688
|
2,419
|
2,755
|
2,906
|
2,577
|
1,200
|
EBIT
1 |
522
|
1,127
|
1,354
|
1,507
|
1,108
|
-402
|
Operating Margin
|
1.86%
|
3.64%
|
3.98%
|
4.14%
|
2.89%
|
-0.98%
|
Earnings before Tax (EBT)
1 |
369
|
519
|
1,051
|
1,467
|
1,019
|
107
|
Net income
1 |
210
|
300
|
711
|
937
|
630
|
6
|
Net margin
|
0.75%
|
0.97%
|
2.09%
|
2.58%
|
1.64%
|
0.01%
|
EPS
2 |
15.50
|
22.05
|
52.54
|
69.63
|
46.79
|
0.4452
|
Free Cash Flow
1 |
390.6
|
1,319
|
1,851
|
681.1
|
-328.5
|
-510.4
|
FCF margin
|
1.39%
|
4.26%
|
5.45%
|
1.87%
|
-0.86%
|
-1.24%
|
FCF Conversion (EBITDA)
|
23.14%
|
54.53%
|
67.2%
|
23.44%
|
-
|
-
|
FCF Conversion (Net income)
|
186.01%
|
439.71%
|
260.37%
|
72.69%
|
-
|
-
|
Dividend per Share
2 |
10.83
|
10.67
|
11.67
|
15.00
|
17.00
|
17.00
|
Announcement Date
|
1/30/19
|
1/30/20
|
1/29/21
|
1/28/22
|
1/27/23
|
1/30/24
|
Fiscal Period: October |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
21,938
|
22,627
|
21,137
|
20,130
|
20,633
|
15,728
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
13
x
|
9.354
x
|
7.672
x
|
6.927
x
|
8.007
x
|
13.11
x
|
Free Cash Flow
1 |
391
|
1,319
|
1,851
|
681
|
-329
|
-510
|
ROE (net income / shareholders' equity)
|
5.86%
|
7.52%
|
14.9%
|
15.8%
|
9.57%
|
0.27%
|
ROA (Net income/ Total Assets)
|
1.13%
|
2.16%
|
2.41%
|
2.55%
|
1.87%
|
-0.74%
|
Assets
1 |
18,650
|
13,857
|
29,442
|
36,742
|
33,652
|
-814.3
|
Book Value Per Share
2 |
266.0
|
320.0
|
380.0
|
503.0
|
480.0
|
408.0
|
Cash Flow per Share
2 |
104.0
|
90.70
|
218.0
|
211.0
|
140.0
|
193.0
|
Capex
1 |
528
|
592
|
674
|
1,031
|
763
|
1,512
|
Capex / Sales
|
1.88%
|
1.91%
|
1.98%
|
2.84%
|
1.99%
|
3.68%
|
Announcement Date
|
1/30/19
|
1/30/20
|
1/29/21
|
1/28/22
|
1/27/23
|
1/30/24
|
|
1st Jan change
|
Capi.
|
---|
| -7.77% | 50.24M | | -13.84% | 85.02B | | +14.48% | 82.37B | | +9.37% | 29.29B | | -11.29% | 17.21B | | -0.36% | 16.7B | | +0.27% | 15.5B | | +4.32% | 12.15B | | -2.34% | 12.13B | | +32.51% | 12.12B |
Other Healthcare Facilities & Services
|